17-7676577-T-G

Variant names:

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_000546.6(TP53):c.18A>C(p.Ser6Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,613,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S6S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 31)

Exomes 𝑓: 0.000018 ( 0 hom. )

Consequence

TP53
NM_000546.6 synonymous

Scores

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -2.31

Publications

17 publications found

Variant links:

Genes affected

TP53 (HGNC:11998): (tumor protein p53) This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]

TP53 Gene-Disease associations (from GenCC):

breast cancer
Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
Li-Fraumeni syndrome
Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet
Li-Fraumeni syndrome 1
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
adrenocortical carcinoma, hereditary
Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
sarcoma
Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
bone marrow failure syndrome 5
Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
colorectal cancer
Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
choroid plexus carcinoma
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

TP53 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.87).

BP6

Variant 17-7676577-T-G is Benign according to our data. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7676577-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 182940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BP7

Synonymous conserved (PhyloP=-2.31 with no splicing effect.

BS2

High AC in GnomAdExome4 at 27 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
TP53	NM_000546.6 link	c.18A>C	p.Ser6Ser	synonymous_variant	Exon 2 of 11	ENST00000269305.9	NP_000537.3	P04637-1K7PPA8Q53GA5

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
TP53	ENST00000269305.9 link	c.18A>C	p.Ser6Ser	synonymous_variant	Exon 2 of 11	1	NM_000546.6	ENSP00000269305.4		P04637-1

Frequencies

GnomAD3 genomes

AF:

0.0000197

AC:

AN:

152094

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.00

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.0000441

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.0000120

AC:

AN:

250726

AF XY:

0.0000147

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.00

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.0000265

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

0.0000185

AC:

AN:

1461816

Hom.:

Cov.:

AF XY:

0.0000193

AC XY:

AN XY:

727194

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

33480

American (AMR)

AF:

0.00

AC:

AN:

44722

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

26134

East Asian (EAS)

AF:

0.00

AC:

AN:

39700

South Asian (SAS)

AF:

0.00

AC:

AN:

86246

European-Finnish (FIN)

AF:

0.00

AC:

AN:

53370

Middle Eastern (MID)

AF:

0.00

AC:

AN:

5768

European-Non Finnish (NFE)

AF:

0.0000234

AC:

AN:

1112000

Other (OTH)

AF:

0.0000166

AC:

AN:

60396

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.475

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.0000197

AC:

AN:

152094

Hom.:

Cov.:

AF XY:

0.0000404

AC XY:

AN XY:

74292

show subpopulations

⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.

African (AFR)

AF:

0.00

AC:

AN:

41402

American (AMR)

AF:

0.00

AC:

AN:

15242

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3466

East Asian (EAS)

AF:

0.00

AC:

AN:

5184

South Asian (SAS)

AF:

0.00

AC:

AN:

4834

European-Finnish (FIN)

AF:

0.00

AC:

AN:

10614

Middle Eastern (MID)

AF:

0.00

AC:

AN:

316

European-Non Finnish (NFE)

AF:

0.0000441

AC:

AN:

68036

Other (OTH)

AF:

0.00

AC:

AN:

2088

⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.001311), which strongly suggests a high chance of mosaicism in these individuals.

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.392

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Alfa

AF:

0.0000282

Hom.:

Bravo

AF:

0.0000529

EpiCase

AF:

0.00

EpiControl

AF:

0.0000593

ClinVar

Significance: Benign/Likely benign

Submissions summary: Benign:12

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not specified

Benign:3

Sep 08, 2014

GeneDx

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Aug 21, 2020

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Mayo Clinic Laboratories, Mayo Clinic

Significance:Likely benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome

Benign:3

May 01, 2017

Color Diagnostics, LLC DBA Color Health

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Oct 20, 2014

Ambry Genetics

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Jun 18, 2022

Genome-Nilou Lab

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Li-Fraumeni syndrome 1

Benign:2

Jun 18, 2022

Genome-Nilou Lab

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Mar 31, 2025

Myriad Genetics, Inc.

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. -

Li-Fraumeni syndrome

Benign:2

Feb 02, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Sep 17, 2023

All of Us Research Program, National Institutes of Health

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

not provided

Benign:1

Sep 30, 2022

Quest Diagnostics Nichols Institute San Juan Capistrano

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Malignant tumor of breast

Benign:1

Department of Pathology and Laboratory Medicine, Sinai Health System

Significance:Likely benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

The TP53 p.Ser6= variant was not identified in the literature nor was it identified in the COGR, LOVD 3.0, UMD-LSDB, or UMD TP53 Mutation, databases. The variant was identified in dbSNP (ID: rs573130482) as "With Uncertain significance, other allele", ClinVar (classified as benign by GeneDx; as likely benign by Ambry Genetics, Invitae and three other submitters; as uncertain significance by one submitter), and in IARC TP53 Database. The variant was identified in control databases in 3 of 245504 chromosomes at a frequency of 0.00001 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the European in 3 of 111324 chromosomes (freq: 0.00003), while the variant was not observed in the African, Ashkenazi Jewish, East Asian, Finnish, Latino, Other, and South Asian populations. The p.Ser6= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.87

CADD

Benign

0.75

(source)

DANN

Benign

0.60

PhyloP100

-2.3

PromoterAI

-0.021

Neutral

(source)

Mutation Taster

=99/1

polymorphism

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over